Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
Launched by BROOKLYN CLINICAL RESEARCH · May 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SWIFT-CORE-101 trial is a study designed to find out if people with conditions like heart disease, obesity, or diabetes can participate in future clinical trials for new treatments. If you join this study, a doctor will first explain everything and get your permission to participate. Then, you'll fill out a survey about your health history and current symptoms, and the staff may check your vital signs, take a blood sample, and perform other simple tests to help determine if you qualify for other studies.
To be eligible, you must be at least 18 years old, and you need to sign a consent form before any study activities begin. However, you cannot participate if you are pregnant, breastfeeding, or have certain health issues that could affect your safety or the study results. If you are interested and meet the criteria, this study could be a great opportunity to help researchers learn more about these health conditions and potentially participate in future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
- • 2. Participant is at least 18 years old.
- Exclusion Criteria:
- • 1. Participant is pregnant, breast-feeding, or planning to become pregnant.
- • 2. History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- • 3. Moderate or severe substance use disorder within 90 days prior to screen
- • 4. Any condition that in the investigator's opinion makes a participant unsuitable for the study.
- • 5. Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.
About Brooklyn Clinical Research
Brooklyn Clinical Research is a leading sponsor in the realm of clinical trials, dedicated to advancing medical knowledge and improving patient outcomes through innovative research methodologies. With a focus on diverse therapeutic areas, the organization collaborates with healthcare professionals and institutions to design and execute rigorous clinical studies. Committed to ethical practices and regulatory compliance, Brooklyn Clinical Research prioritizes patient safety and data integrity, ensuring that each trial contributes valuable insights to the scientific community. Their experienced team leverages state-of-the-art technology and a patient-centered approach to facilitate the efficient and effective progress of clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brooklyn, New York, United States
Patients applied
Trial Officials
Ammara Mushtaq, MD
Principal Investigator
Brooklyn Clinical Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported